Patent details

EP1638569 Title: USE OF BRIMONIDINE FOR PREVENTING AND REDUCING THE SEVERITY OF STRESS-ASSOCIATED CONDITIONS

Basic Information

Publication number:
EP1638569
PCT Application Number:
PCT/US/2004/020194
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP047559810
PCT Publication Number:
WO/2005/002580
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
USE OF BRIMONIDINE FOR PREVENTING AND REDUCING THE SEVERITY OF STRESS-ASSOCIATED CONDITIONS
French Title of Invention:
UTILISATION DE BRIMONIDINE DESTINEE A PREVENIR OU ATTENUER LA GRAVITE D'ETATS ASSOCIES AU STRESS
German Title of Invention:
VERWENDUNG VON BRIMONIDINE ZUR BEHANDLUNG VON STRESS ASSOZIIERTEN ZUSTÄNDEN
SPC Number:

Dates

Filing date:
22/06/2004
Grant date:
04/01/2012
EP Publication Date:
04/01/2012
PCT Publication Date:
13/01/2005
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
29/03/2006
EP B1 Publication Date:
04/01/2012
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
22/06/2012
Expiration date:
22/06/2024
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
22/06/2004
 
 

Name:
ALLERGAN INC.
Address:
2525 Dupont Drive, Irvine CA 92612, United States (US)

Inventor

1

Name:
WHITCUP Scott, M.
Address:
United States (US)

2

Name:
BRIN Mitchell, F.
Address:
United States (US)

3

Name:
DONELLO John, E.
Address:
United States (US)

4

Name:
GIL Daniel, W.
Address:
United States (US)

Priority

Priority Number:
607439
Priority Date:
25/06/2003
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 31/498;
Filing date Document type Number of pages